Pharma manufacturing: People on the move

By Nick Taylor

- Last updated on GMT

Related tags Vice president Vice president of the united states presents its latest round up of personnel moves in pharmaceutical manufacturing.

MacuSight​ has appointed Gerald Wroblewski​ as its new vice president of operations, with the company believing his experience in manufacturing, product supply chain management, packaging and quality assurance will be valuable.

In his new role Wroblewski will apply this knowledge to MacuSight’s Phase II clinical development programme of its lead candidate sirolimus.

Prior to joining MacuSight Wroblewski was chief operating officer at iScience, where he established the company’s operations organisation to support internal commercial good manufacturing practices (GMP).

He has also worked at Oculex Pharmaceuticals where he developed and implemented novel manufacturing systems for the production of multiple product components related to the company's lead drug candidate.

This work helped advance the product and assisted in making Oculex an attractive proposition for Allergen, which subsequently bought the company.

Michael Kamarck​ has been appointed as Wyeth​’s president, technical operations & product supply (TO&PS). In this capacity Kamarck will take responsibility for technical operations and product supply across Wyeth’s pharmaceutical and biologics divisions.

Kamarck joined Wyeth in 2001 and was responsible for the expansion of the company’s biotech manufacturing capacity.

Following this Kamarck was promoted to executive vice president, TO&PS, which gave him responsibility for biotech and pharmaceutical operations at 13 sites around the world. He was also in charge of process development of the late-stage pipeline.

Kamarck replaces Charles Portwood, who has been promoted to the post of executive vice president, TO&PS operational excellence.

Regado Biosciences​ has appointed Alexander Giaquinto​ to the newly created position of senior vice president of regulatory affairs and quality assurance.

Giaquinto has over 35 years of experience in the pharmaceutical industry, including 30 years at Schering-Plough. During his time at Schering, Giaquinto attained the post of senior vice president, worldwide regulatory affairs and also held a special position overseeing global compliance.He has also worked as the US Industry Representative of the Steering Committee of the International Conference on Harmonization (ICH), which has given him an understanding of national and international regulatory processes.

Related topics Markets & regulatory news

Follow us